Cargando…
Dynamic treatment regimes (DTRs) to study treatment sequencing in oncology: a scoping review protocol
INTRODUCTION: The rapid evolution of the therapeutic landscape in oncology poses challenges to optimal treatment sequencing. Evidence for clinical decision-making is often limited to studies focused on treatment evaluation at a single decision point, with limited capability of identifying delayed ef...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10254775/ https://www.ncbi.nlm.nih.gov/pubmed/37253495 http://dx.doi.org/10.1136/bmjopen-2022-067192 |
_version_ | 1785056722073681920 |
---|---|
author | Esteves, Susana Alves, João Miguel Rodrigues, Pedro Pereira Gomes da Silva, Maria |
author_facet | Esteves, Susana Alves, João Miguel Rodrigues, Pedro Pereira Gomes da Silva, Maria |
author_sort | Esteves, Susana |
collection | PubMed |
description | INTRODUCTION: The rapid evolution of the therapeutic landscape in oncology poses challenges to optimal treatment sequencing. Evidence for clinical decision-making is often limited to studies focused on treatment evaluation at a single decision point, with limited capability of identifying delayed effects of prior treatment decisions on the efficacy and feasibility of future treatments. There is a growing interest in dynamic treatment regimes (DTRs) evaluation as it provides guidance on treatment individualisation based on evolving treatment and patient characteristics. In this scoping review we aim to systematically map how and to what extent DTRs have been evaluated in clinical studies to generate evidence for clinical decision-making in oncology. METHODS AND ANALYSIS: We will do a systematic literature search in MEDLINE (PubMed), Web of Science, Scopus and WHO international clinical trials registry platform to identify clinical studies (including protocols of ongoing studies), with either experimental or observational design, that aim to answer a clinical question and explore treatment sequencing issues in oncology using the concept of DTR. Data extraction will comprise information concerning cancer disease, clinical setting, treatments, tailoring variables, decision rules, decision points and outcomes, type of data, study design and statistical methods used for DTR evaluation. The review will be conducted according to Joanna Briggs Institute Reviewer’s manual for scoping reviews. No patients will be involved. ETHICS AND DISSEMINATION: Ethics committee approval is not required as this scoping review will undertake secondary analysis of published literature. Results will be disseminated through a peer-reviewed scientific journal and presented in relevant conferences. This scoping review will provide a better understanding of the methods used to generate evidence on treatment sequencing in oncology and will contribute to the identification of knowledge and methodological gaps that should be addressed. |
format | Online Article Text |
id | pubmed-10254775 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-102547752023-06-10 Dynamic treatment regimes (DTRs) to study treatment sequencing in oncology: a scoping review protocol Esteves, Susana Alves, João Miguel Rodrigues, Pedro Pereira Gomes da Silva, Maria BMJ Open Research Methods INTRODUCTION: The rapid evolution of the therapeutic landscape in oncology poses challenges to optimal treatment sequencing. Evidence for clinical decision-making is often limited to studies focused on treatment evaluation at a single decision point, with limited capability of identifying delayed effects of prior treatment decisions on the efficacy and feasibility of future treatments. There is a growing interest in dynamic treatment regimes (DTRs) evaluation as it provides guidance on treatment individualisation based on evolving treatment and patient characteristics. In this scoping review we aim to systematically map how and to what extent DTRs have been evaluated in clinical studies to generate evidence for clinical decision-making in oncology. METHODS AND ANALYSIS: We will do a systematic literature search in MEDLINE (PubMed), Web of Science, Scopus and WHO international clinical trials registry platform to identify clinical studies (including protocols of ongoing studies), with either experimental or observational design, that aim to answer a clinical question and explore treatment sequencing issues in oncology using the concept of DTR. Data extraction will comprise information concerning cancer disease, clinical setting, treatments, tailoring variables, decision rules, decision points and outcomes, type of data, study design and statistical methods used for DTR evaluation. The review will be conducted according to Joanna Briggs Institute Reviewer’s manual for scoping reviews. No patients will be involved. ETHICS AND DISSEMINATION: Ethics committee approval is not required as this scoping review will undertake secondary analysis of published literature. Results will be disseminated through a peer-reviewed scientific journal and presented in relevant conferences. This scoping review will provide a better understanding of the methods used to generate evidence on treatment sequencing in oncology and will contribute to the identification of knowledge and methodological gaps that should be addressed. BMJ Publishing Group 2023-05-30 /pmc/articles/PMC10254775/ /pubmed/37253495 http://dx.doi.org/10.1136/bmjopen-2022-067192 Text en © Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
spellingShingle | Research Methods Esteves, Susana Alves, João Miguel Rodrigues, Pedro Pereira Gomes da Silva, Maria Dynamic treatment regimes (DTRs) to study treatment sequencing in oncology: a scoping review protocol |
title | Dynamic treatment regimes (DTRs) to study treatment sequencing in oncology: a scoping review protocol |
title_full | Dynamic treatment regimes (DTRs) to study treatment sequencing in oncology: a scoping review protocol |
title_fullStr | Dynamic treatment regimes (DTRs) to study treatment sequencing in oncology: a scoping review protocol |
title_full_unstemmed | Dynamic treatment regimes (DTRs) to study treatment sequencing in oncology: a scoping review protocol |
title_short | Dynamic treatment regimes (DTRs) to study treatment sequencing in oncology: a scoping review protocol |
title_sort | dynamic treatment regimes (dtrs) to study treatment sequencing in oncology: a scoping review protocol |
topic | Research Methods |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10254775/ https://www.ncbi.nlm.nih.gov/pubmed/37253495 http://dx.doi.org/10.1136/bmjopen-2022-067192 |
work_keys_str_mv | AT estevessusana dynamictreatmentregimesdtrstostudytreatmentsequencinginoncologyascopingreviewprotocol AT alvesjoaomiguel dynamictreatmentregimesdtrstostudytreatmentsequencinginoncologyascopingreviewprotocol AT rodriguespedropereira dynamictreatmentregimesdtrstostudytreatmentsequencinginoncologyascopingreviewprotocol AT gomesdasilvamaria dynamictreatmentregimesdtrstostudytreatmentsequencinginoncologyascopingreviewprotocol |